Quale sarebbe il prezzo per PharmaSGP Holding SE (PSG)

Il prezzo per PharmaSGP Holding SE (PSG) è $34.40

Qual è la capitalizzazione di mercato per PharmaSGP Holding SE (PSG)

La capitalizzazione di mercato per PharmaSGP Holding SE (PSG) è $396.01M

PharmaSGP Holding SE (PSG) Margine Operativo

Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.

Anno	Margine Operativo	Cambia
Non abbastanza dati per le date fornite.

Anno

Margine Operativo

Cambia

Non abbastanza dati per le date fornite.

Azienda	Margine Operativo	Differenza del margine operativo	Il paese
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	-	DE
Merck KGaA MRK.DE	0.00%	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	22.93%	-	IN
Galderma Group AG GALD.SW	0.00%	-	CH

Azienda

Margine Operativo

Differenza del margine operativo

Il paese